Found: 4
Select item for more details and to access through your institution.
Metabolism and disposition of the anticancer quinolone derivative vosaroxin, a novel inhibitor of topoisomerase II.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 4, p. 478, doi. 10.1007/s10637-017-0428-1
- By:
- Publication type:
- Article
Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazole.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 2, p. 381, doi. 10.1007/s10637-012-9829-3
- By:
- Publication type:
- Article
Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 6, p. 823, doi. 10.1007/s00280-012-1976-x
- By:
- Publication type:
- Article
Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2015, v. 113, n. 5, p. 706, doi. 10.1038/bjc.2015.257
- By:
- Publication type:
- Article